nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclandelate—CACNA2D1—Pregabalin—epilepsy syndrome	0.423	0.451	CbGbCtD
Cyclandelate—CACNA2D1—Gabapentin—epilepsy syndrome	0.293	0.312	CbGbCtD
Cyclandelate—CES1—Rufinamide—epilepsy syndrome	0.222	0.237	CbGbCtD
Cyclandelate—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—CACNG3—epilepsy syndrome	0.00399	0.089	CbGpPWpGaD
Cyclandelate—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—CACNG2—epilepsy syndrome	0.00371	0.0827	CbGpPWpGaD
Cyclandelate—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—CACNA2D2—epilepsy syndrome	0.0033	0.0737	CbGpPWpGaD
Cyclandelate—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—CACNB4—epilepsy syndrome	0.0033	0.0737	CbGpPWpGaD
Cyclandelate—CES1—Irinotecan Pathway—ABCC2—epilepsy syndrome	0.00326	0.0728	CbGpPWpGaD
Cyclandelate—CES1—Fluoropyrimidine Activity—UPB1—epilepsy syndrome	0.00286	0.0638	CbGpPWpGaD
Cyclandelate—CES1—Irinotecan Pathway—ABCG2—epilepsy syndrome	0.00277	0.0619	CbGpPWpGaD
Cyclandelate—CES1—Irinotecan Pathway—BCHE—epilepsy syndrome	0.0023	0.0513	CbGpPWpGaD
Cyclandelate—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—CACNA1D—epilepsy syndrome	0.00221	0.0492	CbGpPWpGaD
Cyclandelate—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—epilepsy syndrome	0.002	0.0447	CbGpPWpGaD
Cyclandelate—CACNA2D1—hindbrain—epilepsy syndrome	0.00198	0.216	CbGeAlD
Cyclandelate—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—SLC8A1—epilepsy syndrome	0.00187	0.0418	CbGpPWpGaD
Cyclandelate—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—CDH2—epilepsy syndrome	0.00152	0.0338	CbGpPWpGaD
Cyclandelate—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—ATP2A2—epilepsy syndrome	0.00144	0.0321	CbGpPWpGaD
Cyclandelate—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTB—epilepsy syndrome	0.00142	0.0317	CbGpPWpGaD
Cyclandelate—CES1—Fluoropyrimidine Activity—ABCG2—epilepsy syndrome	0.0014	0.0312	CbGpPWpGaD
Cyclandelate—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA2—epilepsy syndrome	0.0014	0.0311	CbGpPWpGaD
Cyclandelate—CACNA2D1—brainstem—epilepsy syndrome	0.00113	0.124	CbGeAlD
Cyclandelate—CACNA2D1—forebrain—epilepsy syndrome	0.00109	0.119	CbGeAlD
Cyclandelate—CES1—Fluoropyrimidine Activity—SMUG1—epilepsy syndrome	0.00107	0.0239	CbGpPWpGaD
Cyclandelate—CES1—NRF2 pathway—SLC6A8—epilepsy syndrome	0.000952	0.0212	CbGpPWpGaD
Cyclandelate—CACNA2D1—head—epilepsy syndrome	0.000627	0.0684	CbGeAlD
Cyclandelate—CES1—head—epilepsy syndrome	0.000601	0.0655	CbGeAlD
Cyclandelate—CACNA2D1—nervous system—epilepsy syndrome	0.000594	0.0648	CbGeAlD
Cyclandelate—CES1—NRF2 pathway—TXNRD1—epilepsy syndrome	0.000594	0.0133	CbGpPWpGaD
Cyclandelate—CACNA2D1—central nervous system—epilepsy syndrome	0.000572	0.0624	CbGeAlD
Cyclandelate—CES1—nervous system—epilepsy syndrome	0.00057	0.0621	CbGeAlD
Cyclandelate—CACNA2D1—cerebellum—epilepsy syndrome	0.000559	0.061	CbGeAlD
Cyclandelate—CES1—central nervous system—epilepsy syndrome	0.000549	0.0598	CbGeAlD
Cyclandelate—CES1—NRF2 pathway—ABCC2—epilepsy syndrome	0.0005	0.0112	CbGpPWpGaD
Cyclandelate—Methylscopolamine bromide—CHRM3—epilepsy syndrome	0.000468	0.0547	CrCbGaD
Cyclandelate—CES1—E2F transcription factor network—SIRT1—epilepsy syndrome	0.000468	0.0104	CbGpPWpGaD
Cyclandelate—CES1—NRF2 pathway—SLC6A1—epilepsy syndrome	0.000465	0.0104	CbGpPWpGaD
Cyclandelate—CACNA2D1—brain—epilepsy syndrome	0.000454	0.0495	CbGeAlD
Cyclandelate—Methylscopolamine bromide—CHRM1—epilepsy syndrome	0.000437	0.051	CrCbGaD
Cyclandelate—CES1—brain—epilepsy syndrome	0.000436	0.0475	CbGeAlD
Cyclandelate—Cyclopentolate—CHRM3—epilepsy syndrome	0.00041	0.0479	CrCbGaD
Cyclandelate—Scopolamine—CHRM3—epilepsy syndrome	0.000398	0.0465	CrCbGaD
Cyclandelate—Cyclopentolate—CHRM1—epilepsy syndrome	0.000382	0.0447	CrCbGaD
Cyclandelate—CES1—E2F transcription factor network—PLAU—epilepsy syndrome	0.000374	0.00835	CbGpPWpGaD
Cyclandelate—CES1—NRF2 pathway—SLC6A4—epilepsy syndrome	0.000372	0.00829	CbGpPWpGaD
Cyclandelate—Scopolamine—CHRM1—epilepsy syndrome	0.000371	0.0434	CrCbGaD
Cyclandelate—Hyoscyamine—CHRM3—epilepsy syndrome	0.000365	0.0427	CrCbGaD
Cyclandelate—Methylscopolamine bromide—CHRM2—epilepsy syndrome	0.000356	0.0416	CrCbGaD
Cyclandelate—CES1—E2F transcription factor network—ATM—epilepsy syndrome	0.000355	0.00793	CbGpPWpGaD
Cyclandelate—Homatropine Methylbromide—CHRM3—epilepsy syndrome	0.000345	0.0403	CrCbGaD
Cyclandelate—Hyoscyamine—CHRM1—epilepsy syndrome	0.000341	0.0398	CrCbGaD
Cyclandelate—CES1—NRF2 pathway—SLC2A1—epilepsy syndrome	0.000336	0.0075	CbGpPWpGaD
Cyclandelate—Homatropine Methylbromide—CHRM1—epilepsy syndrome	0.000322	0.0376	CrCbGaD
Cyclandelate—CES1—NRF2 pathway—HBEGF—epilepsy syndrome	0.000316	0.00705	CbGpPWpGaD
Cyclandelate—Atropine—CHRM3—epilepsy syndrome	0.000311	0.0363	CrCbGaD
Cyclandelate—Ipratropium bromide—CHRM3—epilepsy syndrome	0.000308	0.0359	CrCbGaD
Cyclandelate—Scopolamine—CHRM2—epilepsy syndrome	0.000303	0.0354	CrCbGaD
Cyclandelate—Atropine—CHRM1—epilepsy syndrome	0.00029	0.0339	CrCbGaD
Cyclandelate—Ipratropium bromide—CHRM1—epilepsy syndrome	0.000287	0.0335	CrCbGaD
Cyclandelate—Hyoscyamine—CHRM2—epilepsy syndrome	0.000278	0.0325	CrCbGaD
Cyclandelate—CES1—NRF2 pathway—HMOX1—epilepsy syndrome	0.000276	0.00617	CbGpPWpGaD
Cyclandelate—Homatropine Methylbromide—CHRM2—epilepsy syndrome	0.000263	0.0307	CrCbGaD
Cyclandelate—Cyclopentolate—BCHE—epilepsy syndrome	0.00026	0.0304	CrCbGaD
Cyclandelate—Atropine—CHRM2—epilepsy syndrome	0.000237	0.0276	CrCbGaD
Cyclandelate—Ipratropium bromide—CHRM2—epilepsy syndrome	0.000234	0.0274	CrCbGaD
Cyclandelate—Methylphenidate—SLC6A4—epilepsy syndrome	0.00022	0.0257	CrCbGaD
Cyclandelate—Dexmethylphenidate—SLC6A4—epilepsy syndrome	0.00022	0.0257	CrCbGaD
Cyclandelate—Ephedrine—BCHE—epilepsy syndrome	0.000182	0.0212	CrCbGaD
Cyclandelate—Dexmethylphenidate—CYP2D6—epilepsy syndrome	0.000155	0.0181	CrCbGaD
Cyclandelate—Methylphenidate—CYP2D6—epilepsy syndrome	0.000155	0.0181	CrCbGaD
Cyclandelate—Pseudoephedrine—ADRA2A—epilepsy syndrome	0.000141	0.0165	CrCbGaD
Cyclandelate—Pseudoephedrine—TNF—epilepsy syndrome	0.000133	0.0156	CrCbGaD
Cyclandelate—Pseudoephedrine—SLC6A4—epilepsy syndrome	0.000107	0.0126	CrCbGaD
Cyclandelate—Ipratropium bromide—CYP2D6—epilepsy syndrome	0.000107	0.0125	CrCbGaD
Cyclandelate—Scopolamine—ABCB1—epilepsy syndrome	9.9e-05	0.0116	CrCbGaD
Cyclandelate—Pseudoephedrine—CYP2D6—epilepsy syndrome	7.55e-05	0.00882	CrCbGaD
